Marburgvirus Genomics and association with a large hemorrhagic fever outbreak in Angola

被引:248
作者
Towner, Jonathan S.
Khristova, Marina L.
Sealy, Tara K.
Vincent, Martin J.
Erickson, Bobbie R.
Bawiec, Darcy A.
Hartman, Amy L.
Comer, James A.
Zaki, Sherif R.
Stroher, Ute
da Silva, Filomena Gomes
del Castillo, Fernando
Rollin, Pierre E.
Ksiazek, Thomas G.
Nichol, Stuart T.
机构
[1] Ctr Dis Control & Prevent, Special Pathogens Branch, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, DVRD, Biotechnol Core Facil Branch, Atlanta, GA 30333 USA
[3] Ctr Dis Control & Prevent, SRP, Atlanta, GA 30333 USA
[4] Ctr Dis Control & Prevent, Infect Dis Pathol Activ, Atlanta, GA 30333 USA
[5] Ctr Dis Control & Prevent, DVRD, NCID, Atlanta, GA 30333 USA
[6] Ctr Dis Control & Prevent, Global Aids Program, Atlanta, GA 30333 USA
[7] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB R3E 3R2, Canada
[8] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0W3, Canada
[9] Inst Nacl Saude Publ, Minist Saude, Luanda, Angola
关键词
D O I
10.1128/JVI.00069-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In March 2005, the Centers for Disease Control and Prevention (CDC) investigated a large hemorrhagic fever (HF) outbreak in Uige Province in northern Angola, West Africa. In total, 15 initial specimens were sent to CDC, Atlanta, Ga., for testing for viruses associated with viral HFs known to be present in West Africa, including ebolavirus. Marburgvirus was also included despite the fact that the origins of all earlier outbreaks were linked directly to East Africa. Surprisingly, marburgvirus was confirmed (12 of 15 specimens) as the cause of the outbreak. The outbreak likely began in October 2004 and ended in July 2005, and it included 252 cases and 227 (90%) fatalities (report from the Ministry of Health, Republic of Angola, 2005), making it the largest Marburg HF outbreak on record. A real-time quantitative reverse transcription-PCR assay utilized and adapted during the outbreak proved to be highly sensitive and sufficiently robust for field use. Partial marburgvirus RNA sequence analysis revealed up to 21% nucleotide divergence among the previously characterized East African strains, with the most distinct being Ravn from Kenya (1987). The Angolan strain was less different (similar to 7%) from the main group of East African marburgviruses than one might expect given the large geographic separation. To more precisely analyze the virus genetic differences between outbreaks and among viruses within the Angola outbreak itself, a total of 16 complete virus genomes were determined, including those of the virus isolates Ravn (Kenya, 1987) and 05DRC, 07DRC, and 09DRC (Democratic Republic of Congo, 1998) and the reference Angolan virus isolate (Ang1379v). In addition, complete genome sequences were obtained from RNAs extracted from 10 clinical specimens reflecting various stages of the disease and locations within the Angolan outbreak. While the marburgviruses exhibit high overall genetic diversity (up to 22%), only 6.8% nucleotide difference was found between the West African Angolan viruses and the majority of East African viruses, suggesting that the virus reservoir species in these regions are not substantially distinct. Remarkably few nucleotide differences were found among the Angolan clinical specimens (0 to 0.07%), consistent with an outbreak scenario in which a single (or rare) introduction of virus from the reservoir species into the human population was followed by person-to-person transmission with little accumulation of mutations. This is in contrast to the 1998 to 2000 marburgvirus outbreak, where evidence of several virus genetic lineages (with up to 21% divergence) and multiple virus introductions into the human population was found.
引用
收藏
页码:6497 / 6516
页数:20
相关论文
共 60 条
[1]   Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients [J].
Baize, S ;
Leroy, EM ;
Georges-Courbot, MC ;
Capron, M ;
Lansoud-Soukate, J ;
Debré, P ;
Fisher-Hoch, SP ;
McCormick, JB ;
McCormick, JB ;
Georges, AJ .
NATURE MEDICINE, 1999, 5 (04) :423-426
[2]   VP24 of Marburg virus influences formation of infectious particles [J].
Bamberg, S ;
Kolesnikova, L ;
Möller, P ;
Klenk, HD ;
Becker, S .
JOURNAL OF VIROLOGY, 2005, 79 (21) :13421-13433
[3]   NUCLEOTIDE-SEQUENCE ANALYSIS OF THE L-GENE OF VESICULAR STOMATITIS-VIRUS (NEW-JERSEY SEROTYPE) - IDENTIFICATION OF CONSERVED DOMAINS IN L-PROTEINS OF NONSEGMENTED NEGATIVE-STRAND RNA VIRUSES [J].
BARIK, S ;
RUD, EW ;
LUK, D ;
BANERJEE, AK ;
KANG, CY .
VIROLOGY, 1990, 175 (01) :332-337
[4]   The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3 [J].
Basler, CF ;
Mikulasova, A ;
Martinez-Sobrido, L ;
Paragas, J ;
Mühlberger, E ;
Bray, M ;
Klenk, HD ;
Palese, P ;
García-Sastre, A .
JOURNAL OF VIROLOGY, 2003, 77 (14) :7945-7956
[5]   Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo [J].
Bausch, DG ;
Borchert, M ;
Grein, T ;
Roth, C ;
Swanepoel, R ;
Libande, ML ;
Talarmin, A ;
Bertherat, E ;
Muyembe-Tamfum, JJ ;
Tugume, B ;
Colebunders, R ;
Kondé, KM ;
Pirard, P ;
Olinda, LL ;
Rodier, GR ;
Campbell, P ;
Tomori, O ;
Ksiazek, TG ;
Rollin, PE .
EMERGING INFECTIOUS DISEASES, 2003, 9 (12) :1531-1537
[6]  
Borroto R J, 1997, Rev Panam Salud Publica, V1, P3
[7]   A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever [J].
Bray, M ;
Davis, K ;
Geisbert, T ;
Schmaljohn, C ;
Huggins, J .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) :651-661
[8]   THE COMPLETE NUCLEOTIDE-SEQUENCE OF THE POPP (1967) STRAIN OF MARBURG-VIRUS - A COMPARISON WITH THE MUSOKE (1980) STRAIN [J].
BUKREYEV, AA ;
VOLCHKOV, VE ;
BLINOV, VM ;
DRYGA, SA ;
NETESOV, SV .
ARCHIVES OF VIROLOGY, 1995, 140 (09) :1589-1600
[9]  
Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P308
[10]  
Centers for Disease Control and Prevention/World Health Organization, 1998, INF CONTR VIR HAEM F, P1